🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

Qiagen NV (QGEN)

NYSE
Currency in USD
43.37
-0.68(-1.54%)
Real-time Data
QGEN Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
Day's Range
43.3743.99
52 wk Range
39.0347.44
Key Statistics
Edit
Prev. Close
44.05
Open
43.87
Day's Range
43.37-43.99
52 wk Range
39.03-47.44
Volume
457,904
Average Volume (3m)
1,180,648
1-Year Change
15.68%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
QGEN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
51.95
Upside
+26.37%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period
Show more

Qiagen NV Company Profile

Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID and forensics assay consumables, such as STR assays for human ID, and assays for food contamination; PCR instruments include digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It also offers predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a collaboration with the U.S. FBI; and with Bio-Manguinhos/Fiocruz to detect malaria and dengue. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.

Employees
5900
Market
Germany

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.418
Dividend Yield
2.93%
Industry Median 0.04%
Annualized payout
1.2800
Paid unevenly
5-Years Growth
-
Growth Streak

People Also Watch

106.300
SY1G
-1.98%
56.500
BNRGn
-8.16%
29.71
VNAn
-1.39%
39.020
BOSSn
-5.47%

FAQ

What Is the Qiagen (QGEN) Stock Price Today?

The Qiagen stock price today is 43.37

What Stock Exchange Does Qiagen Trade On?

Qiagen is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Qiagen?

The stock symbol for Qiagen is "QGEN."

Does Qiagen Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 3.00%.

What Is the Qiagen Market Cap?

As of today, Qiagen market cap is 9.67B.

What is Qiagen Earnings Per Share?

The Qiagen EPS is 0.418.

What Is the Next Qiagen Earnings Date?

Qiagen will release its next earnings report on Feb 11, 2025.

From a Technical Analysis Perspective, Is QGEN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.